ALX Oncology Holdings Inc (ALXO) stock
ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.97−0.03 (-3.47%)
Close on Nov 18, 2026Market cap $134.14MP/E –Yield –
ALX Oncology price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
ALX Oncology's price to book ratio was 1.1× on Nov 11, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 0.3× to 4.5×, with a median of 1.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.1× | −0.2 |
| 2025 | Dec 31, 2025 | 1.4× | +0.7 |
| 2024 | Dec 31, 2024 | 0.6× | −3.0 |
| 2023 | Dec 29, 2023 | 3.6× | +2.0 |
| 2022 | Dec 30, 2022 | 1.6× | −0.7 |
| 2021 | Dec 31, 2021 | 2.3× | −10.4 |
| 2020 | Dec 31, 2020 | 12.7× | – |
See a number that looks wrong?